01
Submit the academic result
The researcher provides a concise non-confidential description of the discovery, existing evidence, unmet need and validation gap.
The academic validation gap
Excellent science often stops one experiment too early
A result may be publishable and scientifically important without yet being investable, licensable or ready for pharmaceutical development.
The Foundry pathway
Each stage creates value before the next begins
Projects start non-confidentially. Only scientifically strong and fundable opportunities proceed to deeper review, consortium construction and funded validation.
02
Assess scientific quality and fundability
ADAPT evaluates robustness, translational potential, validation needs, development feasibility and grant readiness.
03
Build the funding strategy
If the project passes the threshold, SoftMining identifies the most suitable call, assembles the international consortium and prepares the application.
04
Complete funded validation
The funded programme performs the decisive biological, mechanistic, DMPK, safety, formulation or preclinical studies agreed for the project.
05
Create a shared pharmaceutical asset
When predefined validation criteria are met, the academic contribution and SoftMining’s development contribution are recognised in the exploitation model.
Foundry infrastructure
Assessment, consortium building and grant execution in one programme
These tools belong to the Academic Foundry pathway and are used together only after the scientific project passes the initial threshold.
AD
ADAPT
Evaluates scientific quality, translational maturity, validation requirements and fundability.
Explore the technical ADAPT architecture →IM
InnoMatch
Identifies complementary international partners and builds the consortium.
FA
FundingAgent
Matches the scientific project with the most suitable competitive funding opportunities.
GC
GrantCompiler
Structures and prepares the submission using project, call and consortium data.
Transparent economics
Funding first. Shared value after validation
Most funded resources remain with the academic science while SoftMining receives the resources needed to build and validate the asset.
When the grant is funded
80% academic activities
20% SoftMining activities
Academic resources support personnel, consumables and validation experiments. SoftMining resources support computational design, coordination and agreed testing work packages.
After successful validation
50% researcher side
50% SoftMining
Exploitation rights in the validated Project Molecules are shared equally, subject to predefined scientific criteria and signed institutional agreements.
Clear rules from the beginning
Scientific independence and commercial logic can coexist
Submission is not an assignment. Rights, milestones and responsibilities become operative only through the relevant institutional and project agreements.
No automatic IP transfer
Initial submission and ADAPT assessment do not, by themselves, transfer rights to SoftMining.
Confidentiality when required
Projects begin with non-confidential information and move to NDA-protected review when appropriate.
Predefined success criteria
Scientific milestones, contributions, budgets and decision gates are agreed before funded work begins.
Transparent exploitation terms
Background IP, publication, licensing and rights in validated Project Molecules are defined contractually.
What the Foundry selects
Strong science with a decisive, fundable validation path
Selection is intentionally selective. SoftMining advances projects where its platform, funding intelligence and development capability can materially change the trajectory.
01Scientific robustness and reproducibility
02Meaningful unmet need and translational relevance
03Experiments capable of changing asset value
04Researcher and institution ready to collaborate
Start non-confidentially
Your research may already contain the basis of a fundable programme
Send a concise description of the scientific result, supporting evidence, unmet need and the experiment that would most change the project’s value.
What you discovered
target · molecule · mechanism
What supports it
experiments · publications · data
What is missing
validation · funding · partners